Text Size

Effect of Dialysate Temperature on Haemodynamic Stability and Haemodialysis Efficiency

This study is currently recruiting participants.
Verified January 2013 by University Hospital, Ghent
Sponsor:
Information provided by (Responsible Party):
University Hospital, Ghent
ClinicalTrials.gov Identifier:
NCT00221598
First received: September 13, 2005
Last updated: January 29, 2013
Last verified: January 2013
History of Changes
  Purpose

Comparison between dialysate temperatures on haemodynamic stability and haemodialysis efficiency.


Condition Intervention
Acute Renal Failure
Chronic Renal Failure
 Procedure: Haemodialysis with different dialysate temperatures

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Effect of Dialysate Temperature on Haemodynamic Stability and Haemodialysis Efficiency

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University Hospital, Ghent:

Primary Outcome Measures:
  • Haemodynamic stability and tolerance [ Time Frame: t0 ] [ Designated as safety issue: No ]

Estimated Enrollment: 40
Study Start Date: June 2005
Estimated Study Completion Date: July 2013
Estimated Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: hemodialysis Procedure: Haemodialysis with different dialysate temperatures
Haemodialysis with different dialysate temperatures is used.

Detailed Description:

Comparison of 4 different dialysate temperatures for haemodialysis of patients with chronic renal failure.

Comparison of 3 different dialysate temperatures for haemodialysis of patients with acute renal failure.

Investigation of the efficiency of haemodialysis of patients with acute renal failure

  Eligibility

Ages Eligible for Study:   21 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Chronic renal failure
  • Acute renal failure
  • Aged between 21-90 years

Exclusion Criteria:

-

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00221598

Contacts
Contact: Annemieke Dhondt, MD, PhD + 32 9 332.45.79 annemie.dhondt@UGent.be

Locations
Belgium
University Hospital Ghent Recruiting
Ghent, Belgium, 9000
Contact: Annemieke Dhondt, MD, PhD     + 32 9 332.45.79     annemie.dhondt@UGent.be    
Sponsors and Collaborators
University Hospital, Ghent
Investigators
Principal Investigator: Annemieke Dhondt, MD, PhD University Hospital, Ghent
  More Information

Additional Information:
Website University Hospital Ghent  This link exits the ClinicalTrials.gov site

No publications provided

Responsible Party: University Hospital, Ghent
ClinicalTrials.gov Identifier: NCT00221598     History of Changes
Other Study ID Numbers: 2005/148
Study First Received: September 13, 2005
Last Updated: January 29, 2013
Health Authority: Belgium: Institutional Review Board

Additional relevant MeSH terms:
Acute Kidney Injury
Kidney Failure, Chronic
Renal Insufficiency
 Kidney Diseases
Urologic Diseases
Renal Insufficiency, Chronic

ClinicalTrials.gov processed this record on May 22, 2013